New CPT Code And Adult Trial Risks Will Challenge Neuromodulation Outlook Yet Offer Some Promise
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
5.1%7D
0%1Y
5.1%7D
0%You can edit this narrative until Dec 8 6:05 AM. Then, changes will post as Updates.